These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Regulation of proinflammatory cytokine expression by Shiga toxin 1 and/or lipopolysaccharides in the human monocytic cell line THP-1. Harrison LM; van Haaften WC; Tesh VL Infect Immun; 2004 May; 72(5):2618-27. PubMed ID: 15102770 [TBL] [Abstract][Full Text] [Related]
9. Shiga Toxin Selectively Upregulates Expression of Syndecan-4 and Adhesion Molecule ICAM-1 in Human Glomerular Microvascular Endothelium. Volokhina EB; Feitz WJC; Elders LM; van der Velden TJAM; van de Kar NCAJ; van den Heuvel LPWJ Toxins (Basel); 2020 Jul; 12(7):. PubMed ID: 32635212 [TBL] [Abstract][Full Text] [Related]
10. Pretreatment of mice with lipopolysaccharide (LPS) or IL-1beta exerts dose-dependent opposite effects on Shiga toxin-2 lethality. Palermo M; Alves-Rosa F; Rubel C; Fernández GC; Fernández-Alonso G; Alberto F; Rivas M; Isturiz M Clin Exp Immunol; 2000 Jan; 119(1):77-83. PubMed ID: 10606967 [TBL] [Abstract][Full Text] [Related]
11. von Willebrand Factor expression in a Shiga toxin-mediated primate model of hemolytic uremic syndrome. Pysher TJ; Siegler RL; Tesh VL; Taylor FB Pediatr Dev Pathol; 2002; 5(5):472-9. PubMed ID: 12196894 [TBL] [Abstract][Full Text] [Related]
12. Induction of apoptosis of human brain microvascular endothelial cells by shiga toxin 1. Ergonul Z; Hughes AK; Kohan DE J Infect Dis; 2003 Jan; 187(1):154-8. PubMed ID: 12508161 [TBL] [Abstract][Full Text] [Related]
13. Lack of specific binding of Shiga-like toxin (verocytotoxin) and non-specific interaction of Shiga-like toxin 2 antibody with human polymorphonuclear leucocytes. Geelen JM; van der Velden TJ; Te Loo DM; Boerman OC; van den Heuvel LP; Monnens LA Nephrol Dial Transplant; 2007 Mar; 22(3):749-55. PubMed ID: 17127697 [TBL] [Abstract][Full Text] [Related]
15. Comparative evaluation of apoptosis induced by Shiga toxin 1 and/or lipopolysaccharides in human monocytic and macrophage-like cells. Harrison LM; Cherla RP; van den Hoogen C; van Haaften WC; Lee SY; Tesh VL Microb Pathog; 2005; 38(2-3):63-76. PubMed ID: 15748808 [TBL] [Abstract][Full Text] [Related]
16. Tumor necrosis factor-α modifies the effects of Shiga toxin on glial cells. Leu H; Sugimoto N; Shimizu M; Toma T; Wada T; Ohta K; Yachie A Int Immunopharmacol; 2016 Sep; 38():139-43. PubMed ID: 27268285 [TBL] [Abstract][Full Text] [Related]
17. Distinct physiologic and inflammatory responses elicited in baboons after challenge with Shiga toxin type 1 or 2 from enterohemorrhagic Escherichia coli. Stearns-Kurosawa DJ; Collins V; Freeman S; Tesh VL; Kurosawa S Infect Immun; 2010 Jun; 78(6):2497-504. PubMed ID: 20308301 [TBL] [Abstract][Full Text] [Related]
18. Is Shigatoxin 1 protective for the development of Shigatoxin 2-related hemolytic uremic syndrome in children? Data from the ItalKid-HUS Network. Ardissino G; Possenti I; Vignati C; Daprai L; Capone V; Brigotti M; Luini MV; Consonni D; Montini G Pediatr Nephrol; 2020 Oct; 35(10):1997-2001. PubMed ID: 32734345 [TBL] [Abstract][Full Text] [Related]
19. Shiga toxin-1 regulation of cytokine production by human glomerular epithelial cells. Hughes AK; Stricklett PK; Kohan DE Nephron; 2001 May; 88(1):14-23. PubMed ID: 11340345 [TBL] [Abstract][Full Text] [Related]
20. Role of tumor necrosis factor alpha in disease using a mouse model of Shiga toxin-mediated renal damage. Lentz EK; Cherla RP; Jaspers V; Weeks BR; Tesh VL Infect Immun; 2010 Sep; 78(9):3689-99. PubMed ID: 20605983 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]